Trosolwyg
Rheolwr Data yn y Ganolfan Ymchwil Treialon (CTR), ganweithio ar frys ar y treialon canlynol:
- SCOPE2
- CORINTH
- PERL
- CYN
Dechreuais weithio yn y CTR ym mis Mai 2016 fel Gweinyddwr Gwyliadwriaeth a Diogelwch.
Roeddwn yn Rheolwr Data ar gyfer ROCS (PDF link) o fis Mehefin 2017-treial cwblhau a PIN (yn aros i gael ei gyhoeddi) o Awst 2018 tan y presennol.
Dechreuais fy swydd bresennol ym mis Mehefin 2017.
- Gwyddoniaeth Biofeddygol (Patholeg Celloedd) MSc (Prifysgol Metropolitan Caerdydd 2014-2015, gan raddio yn 2016). Cyhoeddwyd crynodeb byr o'm traethawd hir (Effaith thymoquinone ar linellau celloedd canser ceg y groth) yn SCAN, cylchgrawn o Gymdeithas Cytopatholeg Prydain, ym mis Ebrill 2016 (Cyfrol 27:1, PDF link).
- Gwyddor Biofeddygol (Ffisioleg) BSc (Prifysgol Caerdydd 2010-2013).
Cyhoeddiad
2026
- Jones, S. E. et al. 2026. PICCOS: study protocol for pressurised intraperitoneal aerosolised chemotherapy (PIPAC) in the management of cancers of the colon, ovary and stomach: a randomised controlled, phase II trial of efficacy in peritoneal metastases. Pleura and Peritoneum (10.1515/pp-2025-0023)
2023
- Mukherjee, S. et al., 2023. Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial. EClinicalMedicine 61 102059. (10.1016/j.eclinm.2023.102059)
Articles
- Jones, S. E. et al. 2026. PICCOS: study protocol for pressurised intraperitoneal aerosolised chemotherapy (PIPAC) in the management of cancers of the colon, ovary and stomach: a randomised controlled, phase II trial of efficacy in peritoneal metastases. Pleura and Peritoneum (10.1515/pp-2025-0023)
- Mukherjee, S. et al., 2023. Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial. EClinicalMedicine 61 102059. (10.1016/j.eclinm.2023.102059)